Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Millions		Total	Total Crown Equity	Common Stock	Paid-in Capital	Accumulated Earnings	Accumulated Other Comprehensive Loss	Treasury Stock	Noncontrolling Interests
Balance at beginning of period at Dec. 31, 2020		$ 2,604	$ 2,198	$ 929	$ 179	$ 4,538	$ (3,193)	$ (255)	$ 406
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		245	211			211			34
Other comprehensive income / (loss)		(5)	(5)				(5)		0
Dividends declared		(27)	(27)			(27)
Dividends paid to noncontrolling interests		(9)							(9)
Restricted stock awarded		0			(1)			1
Stock-based compensation		11	11		11
Common stock issued		1	1		1
Common stock repurchased		(12)	(12)		(11)			(1)
Balance at end of period at Mar. 31, 2021		2,808	2,377	929	179	4,722	(3,198)	(255)	431
Balance at beginning of period at Dec. 31, 2020		2,604	2,198	929	179	4,538	(3,193)	(255)	406
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		549
Other comprehensive income / (loss)		601
Balance at end of period at Sep. 30, 2021		2,887	2,444	929	0	4,396	(2,592)	(289)	443
Balance at beginning of period at Dec. 31, 2020		2,604	2,198	929	179	4,538	(3,193)	(255)	406
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock repurchased		(950)
Balance at end of period at Dec. 31, 2021		2,330	1,912	929	0	3,180	(1,898)	(299)	418
Balance at beginning of period at Mar. 31, 2021		2,808	2,377	929	179	4,722	(3,198)	(255)	431
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		173	128			128			45
Other comprehensive income / (loss)		76	75				75		1
Dividends declared		(26)	(26)			(26)
Dividends paid to noncontrolling interests		(15)							(15)
Restricted stock awarded		0			(1)			1
Stock-based compensation		6	6		6
Common stock repurchased		(298)	(298)		(184)	(100)		(14)
Balance at end of period at Jun. 30, 2021		2,724	2,262	929	0	4,724	(3,123)	(268)	462
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		131	102			102			29
Other comprehensive income / (loss)		530	531				531		(1)
Dividends declared		(26)	(26)			(26)
Dividends paid to noncontrolling interests		(32)							(32)
Stock-based compensation		10	10			10
Common stock repurchased		(435)	(435)			(414)		(21)
Disposition of subsidiary with noncontrolling interests	[1]	(15)							(15)
Balance at end of period at Sep. 30, 2021		2,887	2,444	929	0	4,396	(2,592)	(289)	443
Balance at beginning of period at Dec. 31, 2021		2,330	1,912	929	0	3,180	(1,898)	(299)	418
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		246	216			216			30
Other comprehensive income / (loss)		62	59				59		3
Dividends declared		(27)	(27)			(27)
Dividends paid to noncontrolling interests		(11)							(11)
Restricted stock awarded		0				(1)		1
Stock-based compensation		10	10			10
Common stock repurchased		(350)	(350)			(335)		(15)
Balance at end of period at Mar. 31, 2022		2,260	1,820	929	0	3,043	(1,839)	(313)	440
Balance at beginning of period at Dec. 31, 2021		2,330	1,912	929	0	3,180	(1,898)	(299)	418
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		733
Other comprehensive income / (loss)		(116)
Common stock repurchased		(722)
Balance at end of period at Sep. 30, 2022		2,135	1,666	929	0	3,070	(2,004)	(329)	469
Balance at beginning of period at Mar. 31, 2022		2,260	1,820	929	0	3,043	(1,839)	(313)	440
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		329	295			295			34
Other comprehensive income / (loss)		(117)	(107)				(107)		(10)
Dividends declared		(26)	(26)			(26)
Dividends paid to noncontrolling interests		(13)							(13)
Restricted stock awarded		0				(1)		1
Stock-based compensation		6	6			6
Common stock issued		1	1			1
Common stock repurchased		(250)	(250)			(239)		(11)
Balance at end of period at Jun. 30, 2022		2,190	1,739	929	0	3,079	(1,946)	(323)	451
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		158	127			127			31
Other comprehensive income / (loss)		(61)	(58)				(58)		(3)
Dividends declared		(27)	(27)			(27)
Dividends paid to noncontrolling interests		(10)							(10)
Stock-based compensation		7	7			7
Common stock repurchased		(122)	(122)			(116)		(6)
Balance at end of period at Sep. 30, 2022		$ 2,135	$ 1,666	$ 929	$ 0	$ 3,070	$ (2,004)	$ (329)	$ 469

[1] The amount disposed in 2021 relates to discontinued operations. See Note C for further details.